Furthermore, high levels of ISR effectors DDIT3 and ATF4 correlated with shortened patient survival in Mic60-low GBM and kidney cancer (Fig. 5G) but not Mic60-high BRCA and LUAD (SI Appendix, Fig. S9E). This evidence concerns the gene ATF4 and kidney cancer.